Page last updated: 2024-11-01

nevirapine and Cognition Disorders

nevirapine has been researched along with Cognition Disorders in 2 studies

Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.

Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mora-Peris, B1
Stevens, E1
Ferretti, F1
Underwood, J1
Taylor, S1
Winston, A1
Wise, ME1
Mistry, K1
Reid, S1

Trials

1 trial available for nevirapine and Cognition Disorders

ArticleYear
Evolution of changes in cognitive function after the initiation of antiretroviral therapy.
    AIDS research and therapy, 2016, Volume: 13

    Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Cognition; Cognition Disorders; Emtricitabine, Tenofovir

2016

Other Studies

1 other study available for nevirapine and Cognition Disorders

ArticleYear
Drug points: Neuropsychiatric complications of nevirapine treatment.
    BMJ (Clinical research ed.), 2002, Apr-13, Volume: 324, Issue:7342

    Topics: Adult; Anti-HIV Agents; Cognition Disorders; Female; Humans; Male; Nevirapine; Psychoses, Substance-

2002